North Star Investment Management Corp. - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 215 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
North Star Investment Management Corp. ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$37
-11.9%
940.0%0.00%
Q2 2023$42
-45.5%
940.0%0.00%
Q1 2023$77
-47.6%
940.0%0.00%
Q4 2022$147940.0%0.00%
Q3 2022$0940.0%0.00%
Q2 2022$0940.0%0.00%
Q1 2022$0940.0%0.00%
Q4 2021$0
-100.0%
940.0%0.00%
Q3 2021$1,0000.0%940.0%0.00%
Q2 2021$1,0000.0%940.0%0.00%
Q1 2021$1,0000.0%940.0%0.00%
Q4 2020$1,000940.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders